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l The records of 28 children with the pathological diagno- 
sis of American Burkitt’s lymphoma were reviewed. Twenty- 
three of these children (82%) presented with primary abdom- 
inal tumors and 5 with disease located in the head and neck. 
Twelve required an emergency operation for either intestinal 
obstruction (3). intussusception (5), or appendicitis (4); the 
others underwent an elective exploration for tissue diagno- 
sis. Ten patients had disease localized to one particular site. 
Seven of these 10 children underwent wmpiete resection of 
the tumor including a right colectomy (4), small bowel 
segmental resection (1). tonsillectomy (l), and appendec- 
tomy (1). Eight children had a subtotal resection of the tumor 
(i 90% of tumor burden) and the rest underwent incisional 
biopsies. Following the diagnosis, all patients received che- 
motherapy; 8 (29%) also were treated concurrently with 
radiation therapy. Nineteen patients (70%) remain long-term 
survivors with a mean survival time of 3.6 years. Eight 
patients died of either recurrent disease (6) or sepsis second- 
ary to their chemotherapy, with a mean survival time of 6 
months. Sixteen patients (57%) developed complications 
during their hospitalization that required surgical consulta- 
tion or intervention (acute renal failure [9], pleural effusion 
(21. intestinal obstruction (51, gastric outlet obstruction (11, 
and wound infection [l]). No subsequent treatment of these 
complications resulted in mortality or morbidity. The signifi- 
cant positive determinant for survival was the initial absence 
of either bone marrow or central nervous system involve- 
ment (P < .05). In those children who had complete resection 
of their tumor, survival time was greater than 3.7 years. 
Despite the relatively small number of patients in this series, 
these results suggest that surgical intervention for either 
primary control of the tumor or for management of complica- 
tions occurring during the medical treatment of this disease 
may be responsible for the increased survival presently seen 
in children with American Burkitt’s lymphoma. 
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T HE ROLE OF SURGERY in the management of American Burkitt’s lymphoma remains ill 
defined. Due to its rapid doubling time, the tumor 
spreads quickly, thus bringing it to early medical 
attention. However, Burkitt’s lymphoma is extremely 
sensitive to chemotherapeutic agents that cause an 
initial rapid tumor dissolution and, often, long-term 
remission.’ In light of this response, chemotherapy 
has become the primary treatment modality. As a 
result, the role of surgical resection remains uncer- 
tain. Surgery is required to confirm the diagnosis and 
may be necessary to relieve the common presenting 
symptoms of an “acute abdomen.” In addition, sur- 
gery may be needed for removal or debulking of the 
primary disease, for management of complications of 
the treatment of the disease, and for the provision of 
vascular access for nutritional support and/or dialysis. 
However, several investigators recently have sug- 
gested that surgical intervention with its attendant 
negative physiological effects and the resultant delay 
in the initiation of effective chemotherapy may worsen 
the outcome observed without surgery.* This retro- 
spective analysis attempts to identify and define the 
role of surgery in the management of American 
Burl&t’s lymphoma. 
MATERIALS AND METHODS 
The records of 28 children with the pathological diagnosis of 
American Burkitt’s lymphoma treated at the C.S. Mott Children’s 
Hospital were reviewed. The analysis included age and sex distribu- 
tion along with a description of initial pathological findings. In 
addition, the site of the primary lesion and the presence or absence 
of bone marrow and central nervous system (CNS) involvement 
were identified. The extent of the initial surgery and the extent of 
disease were characterized in an effort to determine whether or not 
surgical resection affected outcome. Localized disease was defined 
as disease confined to one anatomic area. Disseminated disease 
was defined as disease extending beyond the primary site or 
metastatic. Surgical procedures were classified as total resection in 
which all gross tumor was removed, subtotal resection in which 
<9CJ% of all gross tumor was removed, or incisional biopsy. All 
complications were tabulated. 
All patients received chemotherapy, usually including cyclophos- 
phamide, vincristine, and methotrexate with or without corticoster- 
oids. A selected group of patients received external beam radiation 
therapy in addition. All living patients have been followed-up for at 
least 2 years and none have been lost to follow-up. 
RESULTS 
There were 22 boys and 6 girls with an average age 
at presentation of 8.4 years (range 2 to 17 years). 
Twenty-three (82%) of the patients presented with 
abdominal disease, and the rest with disease confined 
to the head or neck. Of the 23 patients with primary 
abdominal disease, 6 had localized tumors and the 
remaining 17 had diffuse intraabdominal spread. All 
patients presenting with disease in head or neck had 
no evidence of dissemination (Table 1). 
Twelve patients presented with findings of an acute 
abdomen requiring emergent operation. This group 
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of 12 included 3 patients with complete intestinal 
obstruction secondary to tumor matting, 5 with irre- 
ducible intussusception with tumor acting as the lead 
point, and 4 patients with suspected appendicitis. 
Additional findings in the group of 23 with abdominal 
disease included an abdominal mass and incomplete 
small bowel obstructions. One patient presented with 
an acute onset of hemiparesis secondary to tumor 
compression of the cord. Four of the 5 patients 
presenting with tumor in the head or neck were 
referred for evaluation of a rapidly enlarging neck 
mass (Table 2). 
Five patients required a right colectomy as their 
original procedure, 4 of whom were cured by the 
operation. Six patients had either an appendectomy 
or segmental small bowel resection, of which only 2 
had complete resection. In only 1 patient with disease 
localized to the head and neck was the tumor com- 
pletely excised. The remaining operations were either 
subtotal resections or incisional biopsies (Table 3). 
Of the 23 patients presenting with tumor in the 
abdomen, 14 remain long-term survivors (61%). Six 
of these 23 had localized disease and underwent 
complete resection for cure. Five of these 6 remain 
disease free (83%). The 1 nonsurvivor died of sepsis 
secondary to an intensive chemotherapy regime for 
initial CNS involvement. Of the 17 patients present- 
ing with disseminated intraabdominal disease, none 
were able to undergo complete resection of all gross 
tumor. Six (35%) underwent subtotal resections and 
the remaining 11 had only biopsies. Only 53% of 
these 17 patients have survived. Furthermore, there 
was no significant difference in disease-free time 
between either of these two latter groups (2.8 v 2.1 
years; Table 4). 
Table 2. Mode of Presentation 
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Right eye ptosis 

















Small bowel resection 3 
Incisional biopsy 15 
Vascular access 16 
Dialysis access 8 
Laminectomy 1 
Tonsillectomy 1 











Among the patients with their primary disease 
localized to the head and neck, none had initial 
evidence of dissemination. All patients in this group 
remain long-term survivors. Interestingly, only one 
patient who underwent a tonsillectomy had a com- 
plete resection. The others underwent biopsy only. 
None of the treated patients experienced any local 
recurrence. 
All 8 nonsurvivors had intraabdominal disease. 
Seven had diffuse nonresectable disease at abdominal 
exploration. In addition, all 8 had early evidence of 
metatases with involvement of either their bone 
marrow or central nervous system. Six of these 8 died 
of recurrent disease despite an initial positive re- 
sponse to chemotherapy. The other 2 deaths were 
due to sepsis secondary to the immunosuppresive 
chemotherapy. The median survival time was 6 months 
following diagnosis. 
Sixteen patients required further surgical consulta- 
tion or intervention during their hospitalization for 
chemotherapy. Nine children developed some degree 
of renal failure secondary to tumor lysis. Eight re- 
quired access surgery for dialysis (7 hemodialysis, 1 
peritoneal). Two patients with recurrent malignant 
effusions required tube thoracostomies. Sixteen pa- 
tients subsequently required long-term vascular ac- 
cess for hyperalimentation and/or chemotherapy. Sur- 
gical consultation was obtained in 5 patients who 
developed signs of intestinal obstruction. Three of 
these 5 patients were successfully managed conserva- 
tively, 1 underwent an enterolysis, and 1 required 
surgical reduction of an intussusception that could 
not be reduced hydrostatically. A 6th patient devel- 
oped biliary obstruction that ultimately required 
operative diversion (Table 5). 
Only one patient developed a postoperative compli- 
cation after his initial surgical procedure. This was a 
wound infection following an appendectomy, requir- 
ing open drainage and broad-spectrum antibiotics. 
Furthermore, no subsequent surgical procedure per- 
formed during chemotherapy resulted in any morbid- 
ity or mortality. 
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5 5 (100) 
5 5 (100) 
Subtotal resection - - 
Biopsy 4 4 
DISCUSSION 
American Burkitt’s lymphoma is being recognized 
more frequently in the pediatric population. Al- 
though this entity was initially reported in the surgical 
literature, current treatment is principally medical. 
The tumor is extremely sensitive to chemotherapy, 
with a reported response rate of over 60%.3 Because 
of this favorable response, the role of surgery in the 
management of this disease has been limited. How- 
ever, some investigators have contended that surgery 
does play an important role in the overall manage- 
ment of this disease.4-6 The initial report of Magrath 
et al of 185 patient’s treated in Kampala demon- 
strated that debulking the tumor improved survival. 
They concluded that this benefit was only achieved 
when > 90% of the tumor was removed.4 Kemeny et 
al, in their review, came to a similar conclusion, 
reporting a significant survival advantage with com- 
plete resection of the primary disease. These authors 
broadened the role of surgery by suggesting that, even 
in patients with disseminated disease, the surgeon 
plays an important role in the secondary management 
of the disease.’ 
This report examines the role surgery played in the 
management of 28 patients with American-Type 
Burkitt’s lymphoma treated at the C.S. Mott Chil- 
Table 5. Complications Requiring Surgery Following Primary 
Treatment of American Burkitt’s Lymphoma 
No. of 
Patients 
Acute renal failure/tumor lysis syndrome 9 
Intestinal obstruction 5 
Requiring celiotomy 2 
Managed conservatively 3 
Biliary obstruction (requiring surgical diversion) 1 
Wound infection 1 
Pleural effusion 2 
dren’s Hospital. All patients required early surgical 
intervention for either diagnosis and/or management; 
70% remain long-term survivors. Among patients 
who underwent complete resection of their abdomi- 
nal tumor, 83% remain disease free with a median 
tumor-free survival of nearly 4 years. Among those 
patients with nonresectable disease in the abdomen 
treated with either incomplete resection or incisional 
biopsy, only 53% remain alive. Inspite of the limita- 
tions of a retrospective review and the small number 
of patients in this series, the data suggest that 
complete resection, when possible, offers the patient 
an improved survival. However, this may merely 
reflect the fact that less disease is more easily com- 
pletely resected. 
Nevertheless, even if complete surgical resection 
was not possible, all patients did require surgical 
intervention at some time during their treatment. 
This involved either emergent celiotomy, early biopsy 
for diagnosis, or the management of the complica- 
tions arising during chemotherapy. None of these 
subsequent surgical interventions resulted in signifi- 
cant morbidity or mortality. Furthermore, this inter- 
vention may have played a significant role in the 
improved survival observed. 
Bone marrow or CNS involvement signifies meta- 
static disease and indicates a poor prognosis.’ This 
observation remained true in the present series. Not 
one patient found to have disease within the bone 
marrow or CNS was a long-term survivor. This 
included a patient who underwent an emergent 
operation with complete resection of gross disease. In 
addition, no patients who developed recurrent dis- 
ease received any benefit from either reresection or 
salvage chemotherapy. 
The patients with primary disease in their head or 
neck represent an interesting group. All remain free 
of disease regardless of the extent of resection ini- 
tially done. This may reflect the absence of dissemi- 
nated disease at presentation. This improved survival 
may also be due to the fact that Burkitt’s lymphoma in 
the head and neck may represent a different biologi- 
cal entity, despite its similar histology. 
The following conclusions may be drawn. Com- 
plete resection results in improved survival. In the 
case of disseminated or metastatic disease, aggressive 
debulking of the tumor should be avoided and chemo- 
therapy should be instituted primarily. Surgical resec- 
tion can be done safely and does not cause significant 
morbidity or mortality. Finally, even if complete 
resection is not possible, surgery will still be required 
for management of the complications occurring dur- 
ing the medical treatment of this disease and may 
contribute to the improved survival observed. 
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